Our response to NICE’s decision not to recommend lenacapavir as PrEP
Last Updated:Our response to the National Institute for Health and Care Excellence (NICE) decision not to recommend lenacapavir as PrEP.
Our response to the National Institute for Health and Care Excellence (NICE) decision not to recommend lenacapavir as PrEP.
National AIDS Trust warns UK's 2030 HIV targets are at risk without cross-government action.
Our response to news that Grindr have paid £26m to settle UK lawsuit over allegedly sharing users' HIV status:
National AIDS Trust are in full support of a briefing from Decrim Now calling for the decriminalisation of sex work.
Charities welcome funding formula milk and sterilising equipment for the infants of all women living with HIV.
Robbie Currie, Chief Executive, reflects on World AIDS Day and the new HIV Action Plan.
A simple injection six times a year can take us to the next stage in the fight against the HIV epidemic.
We comment on the UKHSA's latest HIV data.
To make the vision of the Plan a reality, we must see sustained investment in the NHS, stronger NHS partnerships with community organisations, and a continued focus on tackling inequalities.
HIV organisations have come together to call for the EHRC draft guidelines to be withdrawn
A funding crisis puts Scotland's HIV 2030 targets and support service at risk
Rollout of opt-out HIV testing in hospital emergency departments, and year-round postal testing are vital to end new cases 2030.